Background: Rapid and effective screening of carbapenemase-producing Enterobacteriaceae (CPE) appears essential for adequate patient management and rapid implementation of infection control measures. Most of these screening techniques require a minimum of 24 h of culture. Molecular assays are an exception since these can be achieved within 1 h, but are expensive and usually require specialized facilities and trained personnel. In this context, lateral immunochromatography performed directly from rectal swab samples could represent a cost-effective alternative with a reduced turnaround time.
Introduction
The emergence and dissemination of carbapenemase-producing Enterobacteriaceae (CPE) are a major public health concern. 1 Rapid screening for these pathogens is essential for adequate patient management and rapid implementation of infection control measures. 2 OXA-48, KPC, VIM and NDM are the most prevalent enzymes in Enterobacteriaceae in Europe. 2 In Belgium, OXA-48, KPC, VIM and NDM genes are expressed by 75%, 16.2%, 5.1% and 3.1% of CPE, respectively. 3 Lateral immunochromatography performed directly from clinical samples could represent a rapid and cost-effective alternative to culture and molecular tools. 4 Such an assay was evaluated by Wareham and Abdul Momin 5 for OXA-48 from spiked blood culture bottles and by Nodari et al. 6 directly from spiked rectal swabs and spiked positive blood cultures, both using the OXA-48 K-SeT kit (Coris BioConcept, Gembloux, Belgium). Recently, a multiplex lateral flow assay, OKN K-SeT, was marketed and evaluated for the detection of OXA-48, KPC and NDM CPE from culture colonies, showing a sensitivity and specificity of 100%. 7 In this study, we assessed the performance of the OKN K-SeT for the rapid detection of OXA-48, KPC and NDM CPE directly from rectal swabs of patients in a screening context.
Materials and methods
The evaluation of the method was performed on 149 residual rectal swabs from patients admitted at Cliniques universitaires Saint-Luc-UCL (Brussels, Belgium) and Erasme University hospital (Brussels, Belgium). These included samples which yielded positive growth of CPE after plating on selective culture media for ESBLs and carbapenemases or came from patients with CPE history.
The presence of carbapenem resistance was phenotypically detected by culture on CHROMID CARBA SMART medium (bioMérieux, France) and confirmed by multiplex home-made PCR and/or Xpert-Carba-R (Cepheid, USA) detecting bla NDM , bla VIM , bla IMP , bla KPC and bla OXA-48 genes and a home-made multiplex PCR detecting bla OXA-23 , bla OXA-24 and bla OXA-58 genes. 8 Among these, 29 carbapenemase-non-producing organisms as well as 7 Pseudomonas aeruginosa VIM, 1 P. aeruginosa IMP and 3 Acinetobacter baumannii OXA-23, which belong to the strain collection of the laboratory, were included as negative controls.
OXA-48, KPC and NDM carbapenemase producers were detected using the OKN K-SeT kit from Coris BioConcept according to the manufacturer's recommendations with the following adaptations: instead of using a colony, a rectal ESwab or a faeces sample was resuspended in Amies broth and incubated at 35 C for 2.5 h in 3 mL of trypticase soy broth (TSB) medium in the presence of 0.25 mg/L meropenem. The sample was then centrifuged at a relative centrifugal force of 1800 g (3000 rpm) for 10 min. After discarding the supernatant, the pellet was resuspended in 5 drops (instead of 10) of the kit lysis buffer A (pH 7.5 Tris, NaN 3 ,0.1%) and further processed as recommended by the manufacturer.
The cfu titre of the bacterial suspensions after TSB incubation was determined by serial dilutions in sterile water and plating onto CHROMID ESBL agar (bioMérieux, France) and 5% sheep blood BD TM Columbia agar (Becton Dickinson, Germany).
Sensitivity and specificity were determined by comparing the results of the immunochromatographic test with those of multiplex PCR targeting OXA-48, VIM, IMP, NDM and KPC carbapenemases. 
Results
The molecular analysis confirmed that 82, 5 and 22 samples harboured OXA-48, KPC and NDM carbapenemase resistance genes, respectively (Figure 1) .
Out of 82 OXA-48 PCR-positive samples, 76 were shown to be OXA-48-producing strains using the OKN K-SeT. The six others showed negative results using the OKN K-SeT. Similarly, 19 NDMproducing strains were detected using the OKN K-SeT among the 22 NDM PCR-positive samples. Finally, all five KPC PCR-positive samples were found to be KPC-producing using the OKN K-SeT. The OKN K-SeT test results were negative for the 29 PCR-negative samples ( Figure 1 ) as well as for the VIM, IMP and OXA-23 strains.
Based on these results, the global sensitivity and specificity of this method are 96% and 100%, respectively.
Analyses of serial dilutions of isolates on selective and Columbia agar plates established that the limit of detection (LoD) was between 10 4 and 10 5 cfu/mL for all three enzymes. Fauconnier et al.
Discussion
In Europe, OXA-48 and KPC are becoming the predominant carbapenemase types in Enterobacteriaceae. 2, 9 Since carbapenemase resistance is transferred via plasmids, intestinal carriage of CPE is therefore an important source of transmission in healthcare settings. Consequently, screening tests to detect CPE carriers need to be rapid, able to detect isolates with low-level resistance and to detect low numbers of CPE in patient's flora. 10 Current phenotypic approaches on isolated culture are cheap and do not require specific equipment, but they have to be performed on bacterial colonies following overnight growth. Nucleic acid amplification technology can detect the presence of a specific gene promptly with high performance. 10 Nonetheless, universal screening by molecular methods may not be affordable due to their cost. 4 In this study, the method proved to be highly specific (100%) to detect NDM, OXA-48 and KPC producers, showing no crossreactivity with ESBL, VIM or IMP enzymes. This observation is in line with the results previously reported using the OKN K-SeT. 7 However, six OXA-48 and three NDM PCR-positive samples were shown to be negative using the OKN K-SeT. Among these, two OXA-48 and two NDM strains did not show any growth on Columbia agar plates (i.e. titre of 0 cfu/mL). These four culturenegative, but PCR-positive, samples were not seen as falsenegative results and as such were not factored in when calculating the sensitivity of the method. Indeed, considering the growth on permissive medium as a reference standard, a negative carbapenemase phenotype is the expected outcome of the absence of living bacteria in a sample, which is evidenced by the lack of growth on Columbia agar plates. These four PCR-positive signals may result from the amplification of DNA traces that remain in samples actually devoid of living CPE. The absence of viable bacteria in these PCR-positive isolates could be explained by possible damage or mishandling of the samples. On this basis, the sensitivity of the OKN K-SeT test as applied here could be established at 96%. It is slightly less than the 100% sensitivity from rectal swabs reported by Nodari et al. 6 However, it should be emphasized that they tested spiked samples and not, as reported here, clinical residual samples.
The results obtained for the LoD determination are similar to those published by Nodari et al. 6 (LoD for OXA-48 enzyme of 10 4 cfu/mL). This investigation presented some limitations. Indeed, KPC, which represents the most widely spread type of carbapenemase around the world, is under-represented in this study. Moreover, the carbapenemase coding genes of the false-negative OXA-48 and NDM isolates were not sequenced. Therefore, the possibility of a new variant gene cannot be ruled out.
This study has shown that the OKN K-SeT is an easy and lowcost test for the detection of intestinal carriers of CPE, which could be used as a cost-effective alternative to molecular tools. The kit may be kept for a long time at room temperature, improving the practicability of the test. As compared with the methods that require a 24 h culture product, it significantly reduces the turnaround time. Although this assay appears highly specific, the price to be paid for a reduced turnaround time is reduced sensitivity as compared with the standard procedure, which encompasses a culture step. Nonetheless, this rapid method allows accelerated identification of most CPE carrier patients and, accordingly, the implementation of early appropriate management procedures, which are key elements in the control of hospital infections.
